-
Women's health clinicians will take a hard look at cancer screening regimens now that new guidance has been issued by the U.S. Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists (ACOG).
-
This issue marks the 30th anniversary of Contraceptive Technology Update.
-
With Congress edging closer to enacting broad health care reform legislation, questions abound about its potential impact on patients and providers.
-
Your next patient in the clinic examination room is a 22-year-old who has just delivered her first child three weeks ago.
-
-
Screening STD clinic patients especially men who have sex with men (MSM) for signs of an acute, highly transmissable stage of HIV infection could heighten detection and prevention efforts, the Centers for Disease Control and Prevention.
-
Fatigue is such a common complaint among HIV patients that it's often ignored or expected in clinical care.
-
On Nov. 5, 2009, using expedited review procedures developed to support the President's Emergency Program For AIDS Relief (PEPFAR), the Food and Drug Administration (FDA), granted tentative approval for lamivudine and tenofovir disoproxil fumarate fixed dose combination tablets, 300mg/300mg.
-
The authors describe a fatal case of H1N1 pandemic influenza A associated with pneumonia, which resulted in respiratory and renal failure in a 39-year-old HIV-positive woman.
-
Good news for prevention of HIV and other STDs as a new year dawns. The second-generation FC2 Female Condom is available for purchase in the United States, which gives American women a nonlatex, female-controlled option in disease protection.